Suchergebnisse
Rocket Lab Gets Approval to Acquire Mynaric: Why This Matters
Rocket Lab (NASDAQ: RKLB) has taken a major step forward in its vertical integration strategy. The company announced that it has received regulatory approval to acquire Mynaric, a leading provider
NVIDIA Invests $2B in Marvell: What It Means for Both Stocks
NVIDIA (NASDAQ: NVDA) has announced a slew of multi-billion dollar investments in key artificial intelligence (AI) companies over recent months, and just made its latest splash. Big Green recently
FMC Secures EU Nod for Isoflex Active Herbicide Market Expansion
FMC Corporation FMC has secured the European Union’s (“EU”) approval for its Isoflex active herbicide, marking a major regulatory and strategic milestone as it prepares to enter a constrained
AVNT Stock Trades at a Discounted Valuation: Is it a Buy Signal?
Avient Corporation AVNT is currently trading at a meaningful discount to its industry. The key question is whether that gap reflects an attractive entry point or a fair price for near-term execution
Ulta Beauty Sees Resilient Beauty Demand: How Long Can It Last?
Ulta Beauty Inc. ULTA is showing that demand for beauty products remains solid, even as consumers stay careful with spending. Its fourth-quarter fiscal 2025 update suggests shoppers are still buying
Kura Sushi (KRUS)'s Technical Outlook is Bright After Key Golden Cross
From a technical perspective, Kura Sushi USA, Inc. (KRUS) is looking like an interesting pick, as it just reached a key level of support. KRUS's 50-day simple moving average crossed above its
Is American Assets Trust (AAT) Stock Outpacing Its Finance Peers This Year?
For those looking to find strong Finance stocks, it is prudent to search for companies in the group that are outperforming their peers. Is American Assets Trust (AAT) one of those stocks right now
Alcon Stock Gains Following the Launch of Clareon TruPlus at ASCRS
Alcon ALC recently announced the U.S. launch of Clareon TruPlus, its newly enhanced monofocal and toric intraocular lens (IOL). It was introduced at the American Society of Cataract and Refractive
Oracle's NetSuite Division in Focus: Will it Boost Revenue Growth?
Oracle's ORCL NetSuite division delivered a steady performance in the third quarter of fiscal 2026, but its pace of expansion raises the question of whether the cloud ERP unit can pick up speed and
Is Coherent's Product Range Positioning It as a Premium AI Asset?
Coherent Corp. COHR registered 33.5% year-over-year growth in its datacenter & communications segment’s revenues in the second quarter of fiscal 2026. This segment generated 72% of the top line, a
Genpact (G) Upgraded to Buy: What Does It Mean for the Stock?
Genpact (G) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most
IBM Aktie: Mangelnde Dynamik?
Kurz vor den anstehenden Quartalszahlen weht dem IT-Konzern ein rauer Wind aus Richtung der…
Der Beitrag IBM Aktie: Mangelnde Dynamik? erschien zuerst auf kapitalmarktexperten.de.
Quelle kapitalmark
Unlocking Q4 Potential of Albertsons Companies (ACI): Exploring Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Albertsons Companies, Inc. (ACI) will report quarterly earnings of $0.43 per share in its upcoming release, pointing to a year-over-year decline of 6.5%. It is
Gear Up for Equity Bancshares (EQBK) Q1 Earnings: Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Equity Bancshares (EQBK) will report quarterly earnings of $1.15 per share in its upcoming release, pointing to a year-over-year increase of 27.8%. It is
Countdown to BlackRock (BLK) Q1 Earnings: Wall Street Forecasts for Key Metrics
Wall Street analysts forecast that BlackRock (BLK) will report quarterly earnings of $12.01 per share in its upcoming release, pointing to a year-over-year increase of 6.3%. It is anticipated that
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Return on equity (ROE) is one of the most favored metrics of investors. It is a profitability ratio that measures earnings generated by a company from its equity. Investors can follow the ROE trend
Should You Buy, Sell or Hold JNJ Stock Ahead of Q1 Earnings?
Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its first-quarter 2026 results on April 14. The Zacks Consensus Estimate for first-quarter sales
BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has applied for CE Mark approval for its Liverty TIPS Stent Graft to advance treatment options for portal
Brookdale Senior Q1'26 Sneak Peek: Occupancy Volume Rises to 82.1%
Brookdale Senior Living Inc. BKD recently announced that its March 2026 weighted average occupancy climbed 250 basis points (bps) from the year-ago level to 82%. However, it indicates a 10-bps
Gorilla's Shackleton Deal Clears a Major Hurdle: Here's Why it Matters
Gorilla Technology Group Inc. GRRR recently hit a major milestone with its deal to buy Shackleton Finance after the UK Financial Conduct Authority (FCA) signed off on the change of control needed to



